Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It’s our ‘crown jewel’ — International: Top News And Analysis

Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. …Read More